Rare Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a urothelial or rare genitourinary (urinary/reproductive system) cancer that has been confirmed through a tissue or cell sample test. This includes a wide range of cancer types, such as:
- Small cell carcinoma of the bladder
- Adenocarcinoma of the bladder
- Squamous cell carcinoma of the bladder
- Plasmacytoid urothelial carcinoma
- Any type of penile cancer
- Any type of testicular cancer
- Sarcomatoid renal cell carcinoma (a type of kidney cancer)
- Sarcomatoid urothelial carcinoma
- Renal medullary carcinoma
- Rare subtypes of urothelial carcinoma, including micropapillary, giant cell, lipid-rich, clear cell, and nested variants
- Large cell neuroendocrine carcinoma
- Lymphoepithelioma-like carcinoma
- Mixed cancer patterns
- Small cell neuroendocrine prostate cancer
- Testicular Sertoli or Leydig cell tumours
- Other genitourinary cancers, at the lead doctor's discretion
- People aged 18 years or older
- People who are able to understand the study and are willing to sign a written consent form
Who may not be able to join:
- No exclusion criteria have been listed for this trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Andrea B Apolo, M.D., National Cancer Institute (NCI)
Phone: (240) 858-3236
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
natural history of urothelial and rare genitourinary cancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.